← Back to Compounds
injectableanabolic

Bolandiol

19-Nortestosterone 3β,17β-diol19-Norandrostenediol
35
Anabolic Ratio
15
Androgenic Ratio
2d
Half-Life

Prohormone of 19-nortestosterone (nandrolone) — converts in vivo to nandrolone via enzymatic oxidation. Marketed briefly as an OTC prohormone supplement in the late 1990s/2000s (as 19-norandrostenediol) following the DSHEA loophole era. Effects are those of nandrolone but attenuated by incomplete conversion.

Mechanism of Action

Functions as a pro-drug converted to nandrolone by 3β-HSD. Direct AR activity is minimal; effects are substantially mediated through the nandrolone metabolite. Low androgenicity from the 19-nor structure. Progestogenic activity via nandrolone conversion.

Bolandiol molecule
Molecular structure

Typical Dosing

150 mg
low / week
300 mg
moderate / week
600 mg
high / week

⚠ Warning Flags

  • Converts to nandrolone — doping positive up to 6+ months
  • WADA prohibited — supplements containing this caused mass inadvertent positives

Effect Profile

Muscle Protein Synthesis
4Low
Nitrogen Retention
4Low
Strength Gains
3Low
Red Blood Cell Production
4Low
Fat Loss
2Minimal
Glycogen Storage
4Low
Recovery Speed
4Low
Collagen Synthesis
5Moderate

Side Effect Profile

Hormonal Suppression
5Moderate
Estrogenic Effects
2Minimal
Androgenic Effects
2Minimal
Cardiovascular Strain
3Low
Liver Stress
2Minimal
Insulin Resistance
1Minimal
Mood Changes
3Low
Prostate Risk
1Minimal

Research Studies

Excretion of 19-norandrosterone after administration of 19-norandrostenediol in males

van Eenoo P, et al. · 2001

PubMed

Oral 19-norandrostenediol (bolandiol) supplementation in male volunteers produced detectable urinary 19-norandrosterone (nandrolone metabolite) — demonstrating its conversion to nandrolone and causing inadvertent doping positives in athletes.